Company intelligence / Profile preview

Private Lifescience Investment Group

Not explicitly statedcasdincapital.com ↗

Ownership: Private
Development stage: Phase 2

Overview

LifeScience Investors Group AG specializes in acquiring and managing assets and companies within the life sciences sector. They focus on corporate groups, spin-offs, special situations such as turnarounds and succession planning. Their strategy involves realigning acquired businesses for sustainable growth with operational autonomy remaining with experienced management teams[1].

Industry: Investors

Drug pipeline

4 assets

WVE-006

Clinical

Indications: Alpha-1 antitrypsin deficiency

3 more assets in the full pipeline.

Request access →

Partnerships

Portfolio investments are made alongside independent high-net-worth private investors[1].No specific pharma/biotech partnerships listed.

Beyond the preview

Go deeper on Private Lifescience Investment Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Private Lifescience Investment Group.

Explore the full profile